DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Uniphos Enterprises Limited (UNIENTER) share price today?

Uniphos Enterprises Limited (UNIENTER) is trading at ₹86.59 on the NSE, up 0.45% on the day. Source: DocStoX.

What is the PE ratio of Uniphos Enterprises Limited?

Uniphos Enterprises Limited has a price-to-earnings (PE) ratio of 29.1 in the Chemicals sector.

What is the market capitalisation of Uniphos Enterprises Limited?

Uniphos Enterprises Limited has a market capitalisation of approximately ₹602 crore.

Is Uniphos Enterprises Limited a profitable company?

Uniphos Enterprises Limited generates a return on equity of 0.8% with a net profit margin of 64.7%. That is a modest return on shareholder capital.

What is the 52-week high and low of UNIENTER?

Uniphos Enterprises Limited (UNIENTER) has traded between ₹85.05 and ₹158 over the past 52 weeks, against a current price of ₹86.59.

Does Uniphos Enterprises Limited pay a dividend?

Yes. Uniphos Enterprises Limited currently offers a dividend yield of 3.82%. Dividend payments depend on the board's declaration each year.

Uniphos Enterprises Limited

₹86.59▲ +0.39 (+0.45%)

UNIENTER·NSE·Chemicals

Market Cap

602.48 Cr

PE Ratio

29.06

Volume

2,656

Day High - Low

87.88 - 86.20

52W High-Low

158.00 - 85.05

₹86.59▲ +0.39 (+0.45%)

Market Cap602.48 Cr

PE Ratio29.06

Volume2,656

Day High - Low87.88 - 86.20

52W High-Low158.00 - 85.05

Uniphos Enterprises Limited (UNIENTER): company summary

The company's business has deteriorated significantly, with annual revenue falling 71.4% to ₹32 crore and annual net profit rising 64.7 percentage points to 64.7% despite a net profit of ₹21 crore.

Uniphos Enterprises Limited (UNIENTER) is a micro-cap Chemicals company valued at ₹602 crore operating in Trading - Chemicals on the NSE and BSE.

Recent price move: Uniphos Enterprises Limited last traded at ₹86.59, modestly up 0.45% on the day.
Recent developments: On 2026-07-17, the company announced a dividend of ₹3.50 per share, ex-date. In the latest quarter, revenue collapsed to ₹0 crore, and net profit turned to a ₹1 crore loss, matching the previous quarter's loss. In the prior year's quarter, revenue was ₹6 crore, and net profit was a ₹1 crore loss.
Financial performance: The company's business has deteriorated significantly, with annual revenue falling 71.4% to ₹32 crore and annual net profit rising 64.7 percentage points to 64.7% despite a net profit of ₹21 crore. However, the latest quarter shows a sharp decline, with revenue dropping 100.0% to ₹0 crore and net profit widening to a ₹1 crore loss from a ₹1 crore loss in the previous quarter.
Valuation multiples: The stock trades at 29.1 times earnings, 0.28 times book value. It yields 3.8%.
Things to watch: The company's latest quarter net profit widened to a ₹1 crore loss, matching the previous quarter's loss. Revenue in the latest quarter dropped 100.0% to ₹0 crore, and the stock is 44.9% below its 52-week high. The net profit margin, while up 64.7 percentage points, is based on a very low base.
Where it stands: Uniphos Enterprises Ltd's business has seen a sharp decline in recent quarters, with revenue collapsing to ₹0 crore and net profit turning to a ₹1 crore loss. The stock is 44.9% below its 52-week high, and the company's financials show significant volatility. The most recent figure is the latest quarter net profit of ₹1 crore loss.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

4.3/10

Weak

Fair Value

ROE

0.85%

Weak

P/E

29.06x

Fair

Debt / Equity

0.00

Low

Industry

Chemicals

Trading - Chemicals

Overall View

Weak

Price performance

Day₹86.20

₹87.88

52W₹85.05

₹158.00

DocStoX take

Supported by valuation (7.4) and risk (7.4), but held back by momentum (0.0).

DocStoX score

Low confidence

4.3

/10

Weak

Quality

Weak

ROE 0.8%

Valuation

Fair

P/E 29.1×

Growth

Slow

Revenue +100.0% 5Y CAGR

Risk

Moderate

D/E 0.00

Momentum

Weak

2% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹87

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹602 Cr

52W High / Low

₹158 / ₹85

Dividend Yield

3.82%

Promoter Holding

73.79%

EPS (TTM)

₹2.98

Book Value

₹351.82

Key highlights

Revenue compounding 100% a year
Healthy net margin (65%)
Low leverage — D/E 0.00
Profit shrinking 3% a year
Momentum is weak (0.0/10)

3 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Chemicals stocks · Trading - Chemicals

Explore Uniphos Enterprises Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Uniphos Enterprises Limited peers in Chemicals

Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.

Related tools & concepts

Value Uniphos Enterprises Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

UNIENTER newsLatest coverage & filings Open screenerFilter the whole market